Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/1998
05/28/1998WO1998022149A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33
05/28/1998WO1998022112A1 Drug resistance and multidrug resistance modulators
05/28/1998WO1998022111A1 Anti-helicobacter pylori drugs
05/28/1998WO1998022103A1 Raf kinase inhibitors
05/28/1998WO1998022101A2 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
05/28/1998WO1998021956A1 Heregulin antagonists and methods for their use
05/28/1998WO1998016551A3 Variants of vascular endothelial cell growth factor having antagonistic properties
05/28/1998WO1998016503A3 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/28/1998WO1998016184A3 Purine l-nucleosides, analogs and uses thereof
05/28/1998DE19648793A1 Neue Benzamide und deren Anwendung New benzamides and their application
05/28/1998CA2275438A1 Improved methods for transducing cells
05/28/1998CA2272824A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition
05/28/1998CA2272390A1 Drug resistance and multidrug resistance modulators
05/28/1998CA2272093A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33
05/28/1998CA2271954A1 Identification of bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transduction
05/28/1998CA2271783A1 Survivin, a protein that inhibits cellular apoptosis, and its modulation
05/28/1998CA2271767A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998CA2268770A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998CA2267782A1 Raf kinase inhibitors
05/28/1998CA2217168A1 A polypeptide, and a dna sequence to which a protein containing the polypeptide binds
05/27/1998EP0844305A2 hRAD54
05/27/1998EP0844244A1 Drug resistance and multidrug resistance modulators
05/27/1998EP0844002A1 Use of activated hemicellulose for the induction of interleukin-12
05/27/1998EP0843677A1 4-amino-3-acylnaphthyridine derivatives
05/27/1998EP0843671A1 Heterocyclic compounds and pharmaceutical compositions containing them
05/27/1998EP0843565A1 Coarse spray delivery of functional biologic materials
05/27/1998EP0843557A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
05/27/1998EP0843555A1 Liposomal oligonucleotide compositions
05/27/1998EP0843549A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
05/27/1998EP0786253A4 Agent for suppressing tumour growth
05/27/1998EP0714387B1 New bis-naphthalimides for the treatment of cancer
05/27/1998CN1183099A Pyrido (2, 3 -d) pyrimidines for inbibiting protein tyrosine kinase mediated cellular proliferation
05/27/1998CN1183097A Radiosensitizing diamines and their pharmaceutical preparations
05/27/1998CN1183043A Preparation and use of sulfated oligosaccharides
05/27/1998CN1183039A Novel collagen formulations
05/27/1998CN1182746A Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
05/27/1998CN1182620A Xiaoliushen oral liquid for tumor and preparation method thereof
05/27/1998CN1182591A Improvement for prevention of mammary gland cancer or the prevention of mammary gland canner
05/27/1998CN1182590A Method for prevention of mammary gland cancer
05/26/1998US5756776 Semi-synthetic taxanes with anti-tumoural activity
05/26/1998US5756764 Drug; proteasome inhibitors
05/26/1998US5756733 Vitamin D amide derivatives
05/26/1998US5756699 Immunotoxins comprising ribosome-inactivating proteins
05/26/1998US5756695 Methods of synthesizing GM2
05/26/1998US5756669 Mutants
05/26/1998US5756668 Hypermethylated in cancer polypeptide, HIC-1
05/26/1998US5756535 Antiarrhythmia agents; antiischemic agents; cell antiproliferative agents
05/26/1998US5756512 Treatment of non-small cell lung carcinoma
05/26/1998US5756510 Potentiate effects of cytotoxic drugs or radiotherapy
05/26/1998US5756489 18,19-dinor-vitamin D compounds
05/26/1998US5756486 Cyclized nucleotide; viricide
05/26/1998US5756465 Protease enzyme inhibitors
05/26/1998US5756448 Constitute activator of retinoid (CAR) receptor polypeptides
05/26/1998US5756320 Culturing microorganisms belonging to the genus streptomyces; isolation; exhibit inhibitory action on interleukin-6
05/26/1998US5756284 Self-assembling recombinant papillomavirus capsid proteins
05/26/1998US5756084 Human stromal derived factor 1α and 1β
05/22/1998WO1998021359A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998WO1998021345A1 Hsv/aav hybrid amplicon vectors
05/22/1998WO1998021342A1 Nucleic acid sequences that encode a cell growth regulatory protein and uses thereof
05/22/1998WO1998021333A2 Nucleic acid encoding schwannomin-binding-proteins and products related thereto
05/22/1998WO1998021332A2 Secreted proteins and polynucleotides encoding them
05/22/1998WO1998021331A1 Human breast tumor-specific proteins
05/22/1998WO1998021330A1 Exodus chemokine materials and methods
05/22/1998WO1998021237A2 Peptide compounds useful for modulating fgf receptor activity
05/22/1998WO1998021229A1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them
05/22/1998WO1998021228A1 Tissue specific expression of retinoblastoma protein
05/22/1998WO1998021223A1 Nucleosides
05/22/1998WO1998021202A1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
05/22/1998WO1998021195A1 Indene inhibitors of cox-2
05/22/1998WO1998021186A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998WO1998020909A2 Ex-corpore method for treating human blood cells
05/22/1998WO1998020896A1 A method for inducing apoptosis of primary central nervous system b cell lymphomas
05/22/1998WO1998020884A1 Apoptosis inducers
05/22/1998WO1998020879A1 L-β-DIOXOLANE URIDINE ANALOGS AND METHODS FOR TREATING AND PREVENTING VIRUS INFECTIONS
05/22/1998WO1998020874A1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom
05/22/1998WO1998010795A3 Tumor homing molecules, conjugates derived therefrom, and methods of using same
05/22/1998CA2272404A1 L-.beta.-dioxolane uridine analogs and methods for treating and preventing virus infections
05/22/1998CA2271777A1 Hsv/aav hybrid amplicon vectors
05/22/1998CA2271737A1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom
05/22/1998CA2271705A1 Apoptosis inducing agent
05/22/1998CA2271299A1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
05/22/1998CA2271135A1 Nucleosides
05/22/1998CA2271116A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998CA2270910A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998CA2270875A1 Nucleic acid encoding schwannomin-binding-proteins and products related thereto
05/22/1998CA2270873A1 Secreted proteins and polynucleotides encoding them
05/22/1998CA2270871A1 Peptide compounds useful for modulating fgf receptor activity
05/22/1998CA2270158A1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them
05/22/1998CA2270156A1 Human breast tumor-specific proteins
05/22/1998CA2269035A1 Indene inhibitors of cox-2
05/22/1998CA2263148A1 Nucleic acid sequences that encode a cell growth regulatory protein and uses thereof
05/22/1998CA2242384A1 Exodus chemokine materials and methods
05/20/1998EP0842946A1 Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
05/20/1998EP0842945A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842944A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842943A2 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists
05/20/1998EP0842668A1 Ex-corpore method for treating human blood cells
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
1 ... 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 ... 2211